Interventions to improve return to work in depressed people

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Nieuwenhuijsen, Karen ^a   Faber, Babs ^a   Verbeek, Jos H ^b   Neumeyer Gromen, Angela ^c   Hees, Hiske L ^a   Verhoeven, Arco C ^d   van der Feltz Cornelis, Christina M ^e   Bültmann, Ute ^f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c Deutschen Krankenhausgesellschaft   (Germany)

^d Netherlands Society of Occupational Medicine NVAB   (Netherlands)

^e TILBURG UNIVERSITY   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; DULOXETINE; ESCITALOPRAM; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENELZINE; PLACEBO; SELEGILINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ABSENTEEISM; AEROBIC EXERCISE; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HUMAN; JOB ACCOMMODATION; MAJOR DEPRESSION; META ANALYSIS; OCCUPATIONAL THERAPY; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRODUCTIVITY; PSYCHODYNAMIC PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; RESISTANCE TRAINING; RETURN TO WORK; REVIEW; STRETCHING EXERCISE; SYSTEMATIC REVIEW; WORK DISABILITY; ADULT; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; MEDICAL LEAVE; OCCUPATIONAL HEALTH; PSYCHOLOGY;

ABSENTEEISM; ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; HUMANS; MUSCLE STRETCHING EXERCISES; OCCUPATIONAL HEALTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETURN TO WORK; SICK LEAVE;

EID: 84925221967     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006237.pub3     Document Type: Review

References (120)

1. Agosti V, Stewart JW, Quitkin FM. Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. Journal of Affective. Disorders 1991;23(1):35-41.
2. Bee PE, Bower P, Gilbody S, Lovell K. Improving health and productivity of depressed workers: a pilot randomized controlled trial of telephone cognitive behavioral therapy delivery in workplace settings. General Hospital Psychiatry 2010;32:337-40.
3. Burnand Y, Andreoli A, Kolatte E, Venturini A, Rosset N. Psychodynamic psychotherapy and clomipramine in the treatment of major depression. Psychiatric Services 2002;53(5):585-90.
4. Fantino B, Moore N, Verdoux H, Auray J. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder. Journal of Psychopharmacology 2007;22:107-15.
5. Fernandez JL, Montgomery S, Francois C. Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder. Pharmacoeconomics 2005;23(2):155-67.
6. Hees HL, Vries de G, Koeter MW, Schene AH. Adjuvant occupational therapy improves long-term depression recovery and return-to-work in good health in sick-listed employees with major depression: results of a randomised controlled trial. Occupational and Environmental Medicine 2013;70:252-60.
7. Hollinghurst S, Peters TJ, Kaur S, Wiles N, Lewis G. Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomized controlled trial. British Journal of Psychiatry 2010;197:297-304.
8. Kendrick T, Simons L, Mynors-Wallis L, Gray A, Lathlean J, Pickering R, et al. A trial of problem-solving by community mental health nurses for anxiety, depression and life difficulties among general practice patients. The CPN-GP study. Health Technology Assessment 2005;9(37):1-104.
9. Knekt P, Lindfors O, Sares-Jäske L, Virtala E, Härkänen. Randomized trial on the effectiveness of long-and short-term psychotherapy on psychiatric symptoms and working ability during a 5-year follow-up. Nordic Journal of Psychiatry 2013;67:59-68.
10. Krogh J, Saltin B, Gluud C, Nordentoft M. The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression. Journal of Clinical Psychiatry 2009;70:790-800.
11. Krogh J, Videbech P, Thomsen C, Gluud C, Nordentoft M. DEMO-II trial. Aerobic exercise versus stretching exercise in patients with major depression -a randomized clinical trial. PLOS ONE 2012;7(10):e48316.
12. Lerner D, Adler A, Hermann RC, Hong Chang MS, Ludman EJ, Greenhill A, et al. Impact of a work-focused intervention on the productivity and symptoms of employees with depression. Journal of Occupational and Environmental Medicine 2012;54:128-35.
13. McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA, et al. Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: Randomised controlled trial. British Journal of Psychiatry 2004;185:55-62.
14. Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. Journal of Clinical Psychiatry 1998;59(11):608-19.
15. Noordik E, Klink JJ van der, Geskus RB, Boer MR de, Dijk FJ van, Nieuwenhuijsen K. Effectiveness of an exposure-based return-to-work program for workers on sick leave due to common mental disorders: a cluster-randomized controlled trial. Scandinavian Journal of Work, Environment & Health 2013;39:144-54.
16. Romeo R, Patel A, Knapp M, Thomas C. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care. International Clinical Psychopharmacology 2004;19(3):125-34.
17. Rost K, Smith JL, Dickinson M. The effect of improving primary care depression management on employee absenteeism and productivity. A randomized trial. Medical Care 2004;42(12):1202-10.
18. Schene AH, Koeter MWJ, Kikkert MJ, Swinkels JA, Mc Crone P. Adjuvant occupational therapy for work-related major depression works: randomized trial including economic evaluation. Psychological Medicine 2006;2007(37):3.
19. Schoenbaum M, Unutzer J, Sherbourne C, Duan N, Rubenstein LV, Miranda J, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001;286(11):1325-30.
20. Simon GE, Katon W, Rutter C, Von KorffM, Lin E, Robinson P, et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychological Medicine 1998;28(3):693-701.
21. Vlasveld MC, Feltz-Cornelis CM van der, Adèr HJ, Anema JR, Hoedeman R, Mechelen W van, et al. Collaborative care for sick-listed workers with major depressive disorder: a randomised controlled trial from the Netherlands Depression Initiative aimed at return to work and depressive symptoms. Occupational and Environmental Medicine 2013;70:223-30.
22. Wade AG, Fernandez J, Francois C, Hansen K, Danchenko N, Despiegel N. Escitalopram and duloxetine in major depressive disorder -A pharmacoeconomic comparison using UK cost data. Pharmacoeconomics 2008;26:969-81.
23. Wang PS, Simon SE, Avorn J, Azocar F, Ludman EJ, McCulloch J, et al. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes. JAMA 2007;298(12):1401-11.
24. Aelfers E, Bosma H, Houkes I, Eijk JT van. Effectiveness of a minimal psychological intervention to reduce mild to moderate depression and chronic fatigue in a working population: the design of a randomized trial. BMC Public Health 2013;13:129.
25. Ahola, K, Vuori J, Toppinen-Tanner S, Mutanen P, Honkonen T. Resrcource-enhancing group intervention against depression at workplace: who benefits? A randomized controlled study with a 7-month follow-up. Occupational and Environmental Medicine 2012;69:870-6.
26. Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopulos D, McCulloch C, et al. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. Archives of General Psychiatry 2011;68(1):33-41.
27. Amore M, Jori MC. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study. International Clinical Psychopharmacology 2001;16:317-24.
28. Bakker IM, Terluin B, Marwijk HWJ van, Windt DAWM, Rijmen F van der, Mechelen W van, et al. A cluster-randomized trial evaluating an intervention for patients with stress-related mental disorders and sick leave in primary care. PLOS Clinical Trials 2007;26:1-9.
29. Barbui C, Ostuzzi G, Cipriani A. SSRI plus supportive care more effective than supportive care alone for mild to moderate depression. Evidence Based Mental Health 2009;12(4):109.
30. Bech P, Cialdella P, Haugh MC, Birkett MA, Hours A, Boissel JP, et al. Meta-analysis of randomized controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. British Journal of Psychiatry 2000;176:421-8.
31. Becker DR, Drake RE, Bond GR, Xie H, Dain BJ, Harrison K. Job terminations among persons with severe mental illness. Community Mental Health Journal 1998;34:71-82.
32. Blonk RWB, Brenninkmeijer V, Lagerveld SE, Houtman ILD. Return to work: a comparison of two cognitive behavioural interventions in cases of work-related psychological complaints among the self-employed. Work & Stress 2006;20:129-44.
33. Boyer P, Danion JM, Bisserbe JC, Hotton JM, Troy S. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France. Pharmacoeconomics 1998;13(1 Pt 2):157-69.
34. Brandes VMT. Efficacy of auditory stimulation programs for the treatment of depression, dysthymia and symptoms of burnout -RCT results. European Psychiatry conference. 2011.
35. Brouwers EPM, Bruijne MC de, Terluin B, Tiemens BG, Verhaak PFM. Cost-effectiveness of an activating intervention by social workers for patients with minor mental disorders on sick leave: a randomized controlled trial. The European Journal of Public Health 2007;17(2):214-20.
36. Carlin E. The effect of a motivational interviewing style in cognitive therapy for depression [Dissertation]. http://gradworks.umi.com/34/53/3453319.html 2010.
37. Castillo-Pérez S, Gómez-Pérez V, Calvillo Velasco M, Pérez-Campos E, Mayoral M. Effects of music therapy on depression compared with psychotherapy. The Arts in Psychotherapy 2010;37:387-90.
38. Dick P, Cameron L, Cohen D, Barlow M. Day and full time psychiatric treatment. British Journal of Psychiatry 1985;147:246-9.
39. Dunlop BW, Reddy S, Yang L, Lubaczwewski S, Focht K, Guico-Pabia CJ. Symptomatic and functional improvement in employed depressed patients. Journal of Clinical Psychopharmacology 2011;31:569-76.
40. Eklund M, Wästberg BA, Erlandsson L. Work outcomes and their predictors in the Redesigning Daily Occupations (ReDO) rehabilitation programme for women with stress-related disorders. Australian Occupational Therapy Journal 2013;60:85-92.
41. Erkkilä J, Punkanen M, Fachner J, Ala-Ruona E, Pöntiö I, Tervaniemi M, et al. Individual music therapy for depression: randomized controlled trial. British Journal of Psychiatry 2011;199:132-39.
42. Finley PR, Rens HR, Pont JT, Gess SL, Louie CL, Bull SA, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmocotherapy 2003;23:1175-85.
43. Folke F, Parling T, Melin L. Acceptance and commitment therapy for depression: a preliminary randomized clinical trial for unemployed on long-term sick leave. Cognitive and Behavioural Practice 2012;19:583-94.
44. Forman EM, Shaw JA, Goetter EM, Herbert JD, Park JA, Yuen EK. Long-term follow up of a randomized controlled trial comparing acceptance and commitment therapy and standard cognitive behaviour therapy for anxiety and depression. Behavior Therapy 2012;43:801-11.
45. Furukawa TA, Horikoshi M, Kawakami N, Kadota M, Sasaki M, Sekiya Y, et al. Telephone cognitive-behavioural therapy for subthreshold depression and presenteeism in workplace: a randomized controlled trial. PLOS ONE 2012;7:1-9.
46. Gournay K, Brooking J. The community psychiatric nurse in primary care: an economic analysis. Journal of Advanced Nursing 1995;22(4):769-78.
47. Hackett GI, Boddie HG, Harrison P. Chronic muscle contraction: the importance of depression and anxiety. Journal of the Royal Society of Medicine 1987;80:689-91.
48. Hirani SS, Karmaliani R, McFarlane J, Asad N, Madhani F, Shehzad S. Testing a community derived intervention to promote women's health: preliminary results of a 3-arm randomized controlled trial in Karachi, Pakistan. Southern Online Journal of Nursing Research 2010;10(3):n.a.
49. Hordern A, Burt CG, Gordon WF, Holt NF. Amitriptyline in depressive states: Six-month treatment results. British Journal of Psychiatry 1964;110:641-7.
50. Knekt P, Lindfors O, Laaksonen MA, Renlund C, Haaramo P, Härkänen, et al. Quasi-experimental study on the effectiveness of psychoanalysis, long-term and short-term psychotherapy on psychiatric symptoms, work ability and functional capacity during a 5-year follow-up. Journal of Affective Disorders 2011;132:37-47.
51. Kojima R, Fujisawa D, Tajima M, Shibaoka M, Kakinuma M, Shima S, et al. Efficacy of cognitive behavioral therapy training using brief e-mail sessions in the workplace: a controlled clinical trial. Industrial Health 2010;48:495-502.
52. Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care -a randomized trial. JAMA 2001;286:2947-55.
53. Kuhs H, Färber D, Borgstädt S, Mrosek S, Tölle R. Amitriptyline in combination with repeated late deep deprivation versus amitriptyline alone in major depression. A randomized study. Journal of Affective Disorders 1996;37:31-41.
54. Lagerveld SE, Blonk RWB, Brenninkmeijer V, Wijngaards-de Meij L, Schaufeli WB. Work-focused treatment of common mental disorders and return to work: a comparative outcome study. Journal of Occupational Psychology 2012;17:220-34.
55. Lam RW, McLeod J, Woo C, Michalak EE, Yatham LN, Bond DJ. A systematic review of the treatment effects of antidepressants on occupational functioning. Presented at the International Society for Affective Disorders. UK, 2012.
56. Lexis MAS, Jansen NWH, Huibers MJH, Amelsvoort LGPM van, Berkouwer A, Tjin A, Ton G, et al. Prevention of long-term sickness absence and major depression in high-risk employees: a randomised controlled trial. Occupational and Environmental Medicine 2011;68:400-7.
57. Martinez JM, Katon W, Greist JH, Kroenke K, Thase ME, Meyers AL, et al. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode. International Clinical Psychopharmacology 2012;27:17-26.
58. Meyer B, Berger T, Caspar F, Beevers CG, Andersson G, Weiss M. Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial. Journal of Medical Internet Research 2009;11:e15.
59. Mino Y, Babazono A, Tsuda T, Yasuda N. Can stress management at the workplace prevent depression? A randomized controlled trial. Psychotherapy and Psychosomatics 2006;75:177-82.
60. Morgan AJ, Form AF, Mackinnon AJ. Protocol for a randomized controlled trial investigating self-help email messages for sub-treshold depression: the Mood Memos study. Trials 2011;12:1-9.
61. Mundt JC, Clarke GN, Burroughs D, Brenneman DO, Griest JH. Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education. Depression and Anxiety 2001;13:1-10.
62. Oakes TMM, Meyers AL, Marangell LB, Ahl J, Prakash A, Thase ME, Kornstein SG. Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo. Human Psychopharmacology: Clinical and Experimental 2012;27:47-56.
63. Salminen JK, Karlsson H, Hietala J, Kajander J, Aalto S, Markkula J, et al. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychotherapy and Psychosomatics 2008;77:351-7.
64. Sandahl C, Lundberg U, Lindgren A, Rylander G, Herlofsen J, Nygren ÅN. Two forms of group therapy and individual treatment of work-related depression: a one-year follow-up study. International Journal of Group Psychotherapy 2011;61:539-55.
65. Schmitt AB, Volz HP, Wiedemann K, Fritze J, Loeschmann PA. Therapy effects on working ability by venlafaxine compared to serotonin reuptake inhibitors in the treatment of major depressive disorder of different severity. Gesundheitsökonomie & Qualitätsmanagement 2008;13:269-75.
66. Schoenbaum M, Unutzer J, McCaffrey D, Duan N, Sherbourne C, Wells KB. The effects of primary care depression treatment on patients' clinical status and employment. Health Services Research 2002;37(5):1145-58.
67. Simon GE, Revicki D, Heiligenstein J, Grothaus L, Von KorffM, Katon WJ, et al. Recovery from depression, work productivity, and health care costs among primary care patients. General Hospital Psychiatry 2000;22(3):153-62.
68. Sir A, D'Souza RF, Uguz S, George T, Psych MRC, Vahip S, et al. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms. Journal of Clinical Psychiatry 2005;66:1312-20.
69. Stant AD, TenVergert EM, Kluiter H, Conradi HJ, Smit A, Ormel J. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care. The Journal of Mental Health Policy and Economics 2009;12:195-204.
70. Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unutzer J, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000;283(2):212-20.
71. Zambori J, Szadoczky E, Rozsa S, Furedi J. Cost-outcome of anxiety treatment intervention in primary care in Hungary. The Journal of Mental Health Policy and Economics 2002;5(3):115-20.
72. Zeeuw ELEJ de, Tak ECPM, Dusseldorp E, Hendriksen IJM. Workplace exercise intervention to prevent depression: a pilot randomized controlled trial. Mental Health and Physical Activity 2010;3:72-7.
73. Beurden KM, Brouwers EP, Joosen MC, Terluin B, Klink JJ, Weeghel J. Effectiveness of guideline-based care by occupational physicians on the return-to-work of workers with common mental disorders: design of a cluster-randomized controlled trial. BMC Public Health 2013;13:1-8.
74. Geraedts AS, Kleiboer AM, Wiezer NM, Mechelen W van, Cuijpers P. Web-based guided self-help for employees with depressive symptoms (Happy@Work): design of a randomized controlled trial. BMC Psychiatry 2013;13:1-10.
75. Heer EW de, Dekker J, Van Eck-Sluijs JF van der, Beekman ATF, Marwijk HWJ van, Holwerda TJ, et al. Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled muli-Centre trial: TCC: PAINDIP. BMC Psychiatry 2013;13:1-14.
76. Hellstrom L, Bech P, Nordentoft M, Lindschou J, Eplov LF. The effect of IPS-modified, an early intervention for people with mood and anxiety disorders: study protocol for a randomized clinical superiority trial. Trials 2013;14:1-10.
77. Warmerdam L, Straten A van, Cuijpers P. Internet-based treatment for adults with depressive symptoms. BMC Psychiatry 2007;7:1-7.
78. Adler DA, McLaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D. Job performance deficits due to depression. American. Journal of. Psychiatry 2006;163(9):1569-76.
79. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th Edition. Washington, DC: American Psychiatric Association, 1994.
80. American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder. 3rd edition. American Journal of Psychiatry. Arlington (VA): American Psychiatric Association (APA), 2010:152.
81. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013.
82. Beck AT, Steer RA. BDI: Beck Depression Inventory Manual. New York, NY: Psychological Corporation, 1987.
83. Bowling A. What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life. Social Science and Medicine 1995;41(10):1447-62.
84. Brown MM, Brown GC. Update on value-based medicine. Current Opinion in Ophthalmology 2013;24(3):183-9.
85. Burton WN, Pransky G, Conti DJ, Chen CY, Edington DW. The association of medical conditions and presenteeism. Journal of Occupational and Environmental Medicine 2004;46(6 Suppl):S38-S45.
86. Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, et al. Exercise for depression. Cochrane Database of Systematic Reviews 2013;Sep 12;9:CD004366:doi: 10.1002/14651858.CD004366.pub6.
87. Dewa CS, Lin E. Chronic physical illness, psychiatric disorder and disability in the workplace. Social Science and Medicine 2000;51(1):41-50.
88. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-80.
89. Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacology Bulletin 1997;33(1):13-6.
90. Ferrari AJ, Charlson FJ, Norman RE, Flaxman AD, Patten SB, Vos T, et al. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS One 2013;8(7):e69637. doi: 10.1371/journal.pone.0069637.
91. Ferrie JE, Kivimaki M, Head J, Shipley MJ, Vahtera J, Marmot MG. A comparison of self-reported sickness absence with absences recorded in employers' registers: evidence from the Whitehall II study. Occupational and Environmental Medicine 2005;62(2):74-9.
92. Freemantle N. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?. BMJ 2001;322(7292):989-91.
93. Furlan AD, Gnam WH, Carnide N, Irvin E, Amick BC 3rd, DeRango K, et al. Systematic review of intervention practices for depression in the workplace. Journal of Occupational Rehabilitation 2012;22(3):312-21.
94. Brozek J, Oxman A, Schünemann H. GRADEpro. 3.2 for Windows. GRADE working group, 2008.
95. Haafkens J, Moerman C, Schuring M, van Dijk F. Searching bibliographic databases for literature on chronic disease and work participation. Occupational Medicine 2006;56(1):39-45.
96. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967;6(4):278-96.
97. Haslam C, Atkinson S, Brown S, Haslam RA. Perceptions of the impact of depression and anxiety and the medication for these conditions on safety in the workplace. Occupational and Environmental Medicine 2005;62(8):538-45.
98. Hees HL, Koeter MW, Schene AH. Longitudinal relationship between depressive symptoms and work outcomes in clinically treated patients with long-term sickness absence related to major depressive disorder. Journal of Affective Disorders 2013;148(2-3):272-7.
99. Higgins JPT, Green S (editors). The Cochrane Collaboration, 2011. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, 2011. Available from www.cochrane-handbook.org, 2011.
100. Hirschfeld RM, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Moller HJ, et al. Social functioning in depression: a review. Journal of Clinical Psychiatry 2000;61(4):268-75.
101. Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RM, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. American Journal of Psychiatry 2006;163(9):1561-8.
102. Kessler RC, Aguilar-Gaxioloa S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: An update from the WHO World Mental Health (WMH) Suveys. Epidemiologia e Psichiatria Sociale 2009;18(1):23-33.
103. Lagerveld SE, Bültmann U, Franche RL, van Dijk FJ, Vlasveld MC, van der Feltz-Cornelis CM, et al. Factors associated with work participation and work functioning in depressed workers: a systematic review. Journal of Occupational Rehabilitation 2010;20(3):275-92.
104. Lerner D, Henke RM. What does research tell us about depression, job performance, and work productivity?. Journal of Occupational and Environmental Medicine 2008;50(4):401-10.
105. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-9.
106. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223.
107. National Collaborating Centre for Mental Health. The treatment and management of depression in adults (updated edition). http://www.nice.org.uk/nicemedia/live/12329/45896/45896.pdf. Leicester & London: The British Psychological Society and The Royal College of Psychiatrists, 2010.
108. Nieuwenhuijsen K, Franche RL, van Dijk FJH. Work functioning measurement: tools for occupational mental health research. Journal of Occupational and Environmental Medicine 2010;52(8):778-90.
109. Pole JD, Franche RL, Hogg-Johnson S, Vidmar M, Krause N. Duration of work disability: a comparison of self-report and administrative data. American Journal of Industrial Medicine 2006;49(5):394-401.
110. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2012.
111. Severens JL, Mulder J, Laheij RJ, Verbeek AL. Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands. Social Science and Medicine 2000;51(2):243-9.
112. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. International Clinical Psychopharmacology 1996;11 Suppl 3:89-95.
113. Spitzer RL, Endicott J, Williams JB. Research diagnostic criteria. Archive of General Psychiatry 1979;36(12):1381-3.
114. Suzuki K, Ohida T, Kaneita Y, Yokoyama E, Miyake T, Harano S, et al. Mental health status, shift work, and occupational accidents among hospital nurses in Japan. Journal of Occupational Health 2004;46(6):448-54.
115. Timbie JW, Horvitz-Lennon M, Frank RG, Normand SL. A meta-analysis of labor supply effects of interventions for major depressive disorder. Psychiatric Services 2006;57(2):212-8.
116. van Poppel MN, de Vet HC, Koes BW, Smid T, Bouter LM. Measuring sick leave: a comparison of self-reported data on sick leave and data from company records. Occupational Medicine 2002;52(8):485-90.
117. Verbeek J, Salmi J, Pasternack I, Jauhiainen M, Laamanen I, Schaafsma F, et al. A search strategy for occupational health intervention studies. Occupational and Environmental Medicine 2005;62(10):682-7.
118. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262(7):914-9.
119. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization, 1992.
120. Nieuwenhuijsen K, Bültmann U, Neumeyer-Gromen A, Verhoeven AC, Verbeek JH, Feltz-Cornelis CM. Interventions to improve occupational health in depressed people. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD006237.pub2]